Biomatter is a Lithuania-based biotechnology company developing an AI-first platform for on-demand enzyme design to support biotech and pharmaceutical R&D.
Its Intelligent Architecture™ combines generative models, including ProteinGAN, with physics-based engines to design functional enzymes rapidly, aiming to accelerate product development and reduce timelines.
Leadership & Board
Currently, no data available
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$7M
Total Amount Raised$7M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$7M
Latest Funding Amount$7M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jun 02, 2026
Seed Round
$6.50M
―
Similar Companies
A snapshot of private companies similar to Biomatter, helping you discover and navigate related company profiles.